Precision IBD is a Biotechnology company and operator of a drug development precision medicine company intended to develop therapeutics for inflammatory bowel diseases.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Prometheus Biosciences Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Prometheus Biosciences Inc market cap is $9.56B.
What is the 52-week high for Prometheus Biosciences Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Prometheus Biosciences Inc 52 week high is $199.98 as of September 19, 2025.
What is the 52-week low for Prometheus Biosciences Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Prometheus Biosciences Inc 52 week low is $25.65 as of September 19, 2025.
What is Prometheus Biosciences Inc stock price today?
Prometheus Biosciences Inc stock price today is $199.92.
What was Prometheus Biosciences Inc stock price yesterday?
Prometheus Biosciences Inc stock price yesterday was $199.74.
What is the PE ratio of Prometheus Biosciences Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Prometheus Biosciences Inc’s P/E ratio is -57.34.
What is the Price-to-Book ratio of Prometheus Biosciences Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Prometheus Biosciences Inc P/B ratio is 13.8536.
What is the 50-day moving average of Prometheus Biosciences Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Prometheus Biosciences Inc 50-day moving average is $186.01.